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Oxidation of DNA Bases by Tumor
Promoter-Activated Processes
by Krystyna Frenkel*
Evidence has accumulated showingthat active oxygen species participate in at least one stage oftumorpro-
motion. Tumor promoters can induce various types ofcells to undergo processes that result in formation of
active oxygen species. They stimulate polymorphonuclear leukocytes (PMNs) to undergo an oxidative burst
that is characterized byrapid formation of * 0- and H202. We find that in vitro formation ofH202 by tumor
promoter-activated PMNs correlates with their in vivo first-stage promoting activity. Moreover, two thymi-
dine derivatives are formed in DNA coincubated with tumor promoter-stimulated PMNs:
5-hydroxymethyl-2'-deoxyuridine (HMdU) and thymidine glycol (dTG). The amounts ofHMdU and dGl formed
correlate with the first-stage tumor-promoting potencies ofthe agents used for PMN stimulation and with
the amount ofH202 generated. We find thatHMdU is alsoformed in the DNAofHeLa cells coincubated with
12-0-tetradecanoylphorbol-13-acetate (TPA)-activated PMNs, with the amount ofHMdU beingproportional
to that ofTPA used. Even in the absence ofPMNs, HMdU is increasingly formed in cellular DNA with in-
creased TPAconcentration, although atmuch lowerlevels than in thepresence ofPMN&s When rat livermicro-
somes are incubated with benzo[a]pyrene (BaP), acomplete carcinogen, H202 is also generated. Production
ofH202 increases linearly with increasing concentrations ofBaP. Furthermore, HMdU is formed in DNAex-
posed to BaP-treated microsomes, and its formation is ithibited by catalase. These results suggest that
carcinogen-induced processes generating H202 are associated with the first-stage promoting activity ofcom-
plete carcinogens.
Introduction
It has been well established that the tumor-initiating
properties ofcarcinogens correlate with the formation of
certain types ofadducts with DNA bases (1-5). However,
the mechanism of tumor promotion is not as yet clearly
understood. In the last decade, a hypothesis of the mul-
tistage process ofpromotion proposedby Boutwell(6)has
received experimental support. As ofnow, there seem to
be two recognizable stages of promotion followed by
progression from papillomas to the malignant tumors
(7-12).
It has been assumed for many years that modification
ofthe genetic material occurs only at the initiation stage.
However, more recent evidence shows thatifthe so-called
first-stage promoters are applied eitherafter, or evenbe-
fore, aninitiatingagent andused in small enough amounts
so as not to cause formation oftumors, tumorgrowth can
be induced by application ofthe second-stage promoters
weeks later(9,11). These findings suggest that the first-
stage promotional processes involve heritable DNA
modification. This raises a number of questions: What
type or types of DNA modification may constitute the
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first-stage promotional event(s)? Whatprocesses resultin
the formation ofthose modifications? An analysis ofre-
cent publications shows that tumorpromoters induce cel-
lular changes that lead to DNA damage and that active
oxygen speciesgenerated asintermediates areresponsi-
ble for this damage (13-19).
Activation of Polymorphonuclear
Leukocytes
It is quite well known thatpolymorphonuclear leuko-
cytes (PMNs) can be activated by tumor promoters and
that such activation leads to formation oflarge amounts
ofactive oxygen speciesin aprocessthatis oftenreferred
to as an oxidative burst (20-23). A normal function of
PMNs, cells which takepart in theinflammatory and im-
mune responses, is torecognize, phagocytize, and destroy
foreign objects such asbacteria and otheropsonized par-
ticles. When these cells are activated by nonphagocytic
stimuli such as tumorpromoters, large amounts ofgener-
ated active oxygen species are free to interact wvith the
neighboring cells and impart their damaging effects on
the cellular macromolecules, including DNA. Regardless
ofthe type ofstimuliused, the elicitedburstis character-
izedby arapid consumption ofoxygenfollowedby the al-
most concomitantproductionofsuperoxide anionradicalsK FRENKEL
( O2) (23-25). These radicals can dismutate both spon-
taneously andenzymatically to hydrogen peroxide (H202),
which is the immediate precursor ofthe actual bacterio-
cidal species that include hydroxyl radicals(* OH), hypo-
chlorite ions, and singlet oxygen (Fig. 1) (23-26). H202 is
the only one ofthe active oxygen speciesgenerated that
is capable of easily crossing cellular membranes and of
gettinginto the nucleus (23,27). Other species need either
the presence ofanion channels or are too reactive to mi-
grate through the membranes.
It hasbeen knownfor sometime that active oxygen spe-
cies generated byphagocytic cells, both PMNs and mac-
rophages, induce formation ofDNA strandbreaks in coin-
cubated cells (13,14). Formation of these strand breaks
could be prevented by catalase, which points to H202 as
the oxygen speciesresponsible for thistype ofDNAdam-
age. Because H202 by itself cannot interact with DNA,
another species derived from it must be the ultimate
damaging agent (27,28). It was shown that sister chro-
matid exchanges induced by H202 canbepreventedbyus-
ingo-phenanthroline, an iron chelator, which is capable of
crossing cellularmembra4es (29). Thisfinding proves that
it is a transition metal ion-induced decomposition prod-
uctofH202 thatisresponsible for DNAbreaks. The most
likely candidate forthe ultimate damaging agent is *OH,
which is known to be formed from H202 by Fe2+
(26,30,31). Metal ions do not exist in a free state in cells
except in some diseases (30,31). Metal ions are present as
metalloproteins and are chelated to certain amino acids
such as histidine or to phosphate groups of DNA. Thus,
when H202 migrates into the nucleus, it may be reduced
in situ to * OH bymetal ions chelated to DNA orproteins
of chromatin. DNA breaks caused by this type ofinter-
action are termed site specific. Although it seems that
*OH or *OH-like species isultimatelyresponsible forthe
DNA damage, it is H202 that is stable and unreactive
enough to travel into the nucleus thatinitiates the damag-
ingprocess. For this reason, this laboratory has examined
in some detail formation of H202 by PMNs.
Formation of H202 by Tumor
Promoter-Activated PMNs
It has been knownfor sometime that tumor promoters
of the phorbol ester type such as 12-0-tetradecanoyl-
phorbol-13-acetate (TPA), mezerein (Mez), and teleocidins
can stimulate PMNs (12,22). Recently, non-TPA type tu-
mor promoters such as palytoxin and thapsigargin were
shown to activate phagocytic cells as well (32). This sug-
gests that induction ofthe oxidative burst in phagocytes
may be common among tumor promoters. Mez, a potent
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FIGURE 1. Generation of active oxygen species by PMNs.
second-stage promoterand afirst-stage promoterweaker
than TPA (12), caused formation of * 0- at levels that
were comparable to those induced by TPA (33). These
results led to a conclusion that formation ofactive oxygen
species by PMNs stimulated with tumor promoters does
not correlate with the first-stage promotion. This labora-
tory has postulated that it is H202, an immediate precur-
sor of the DNA damaging species * OH, and not *0 2,
that correlates with the first-stage activity (34). It is
known that, depending-on the stimuli, varying percen-
tages ofgenerated *0 - dismutate to H202 (21,35) and,
therefore, formation of * 0 does not have a predictive
value as to how much H202 (and ultimately * OH) is
produced.
In the Absence of Plasma
In order to determine whether this hypothesis is cor-
rect, three tumorpromoters were used (34): TPA, a com-
plete tumor promoter with a potent first-stage activity
(8,12); Mez; and 12-0-retinoylphorbol-13-acetate (RPA).
RPA is a predominantly second-stage promoter with a
weak first-stage activity (8), except in SENCAR mice
where it is quite potent as the first-stage promoter (36).
As shown in Figure 2, all three tumor promoters cause
formation ofincreasing amounts ofH202 as a function of
tumor promoter when incubated with human PMNs at
370C for 30 min. Only 2.5 nM TPA is required to achieve
maximal activation ofPMNs(10PM H202), whereas 5 nM
Mez and 15 nM RPA are needed to obtain maximal levels
ofH202 (9.1 MM and8.9 AM, respectively), which are lower
than that caused by 2.5 nM TPA. TPA-activated PMNs
produce up to 4 and 10 times more H202 than those acti-
vated by Mez and RPA, respectively, when used at con-
centrations between 0.5 nM and 15 nM to stimulate
7.5-8.5x104 PMNs/mL. These differences are highly sig-
nificant withp < 0.001 (normal distribution z-test) at all
data points except one. When PMNs are incubated with
tumorpromoters fortimeperiods between 10 and 60 min
at a concentration that causesmaximalformation ofH202,
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FIGURE 2. Formation of H202 by PMNs (1 x 105/mL) activated with
various concentrations ofTPA (0-0), Mez (A --A) and RPA (A-
--A)
and incubated at 370C for 30 min. Left abscissa: absorbance at 590
nm. Right abscissa: concentration of H202 as read from a standard
curve. Reprinted from Frenkel and Chrzan (34).
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this difference between promoters is even more apparent,
as shown in Figure 3A. Thus, it is quite evident that TPA
is the most active and RPA the least, whereas phorbol,
a nonpromoting parent ofTPA, is totally inactive in this
assay. These findings show thatformation ofH202 by ac-
tivated PMNs correlates with the in vivo first-stage tu-
mor promoting potency of the agents used for that acti-
vation.
In the Presence of Plasma
Since anormal biological milieu ofPMNs is serum, the
same type of experiments were carried out in the pres-
ence of 10% autologous plasma containing all ofthe com-
ponents ofthe blood except for the red and white blood
cells (36). As Figure 3B shows, the accumulation ofH202
decreases significantly in the presence of plasma in the
case ofall three tumorpromoters that were used. It is not
known what causes that decrease. It could be an inhibi-
tion ofH202 formation, as plasma contains some protease
inhibitors, and we found that chymotrypsin-specific inhib-
itors decrease H202 formation by TPA-activated PMNs
(37). Such decrease in the accumulation ofH202 could also
occur when H202 interacts with some Fe-containing pro-
teins. Catalase is present only in small amounts in serum
and, therefore, should not have much influence. However,
there are peroxidases (22,38,39) that may catalyze oxida-
tion ofcertain components of serum, and such an occur-
rence could compete with the horseradish peroxidase-
mediated oxidation of phenol red, on which our assay is
based.
Whatever the reason or combination of reasons for the
decrease in the accumulation ofH202, that inhibition oc-
curs regardless ofwhich tumor promoter is used for the
activation of PMNs. However, the degree of that inhibi-
tion differs, being the highest for RPA, followed by Mez,
and lowest for TPA. This is most apparent at 10 min in-
cubation time in the presence of plasma at which there
is no detectable H202 in the case of RPA as the PMN ac-
tivator (Fig. 3B), whereas there is 1.6,M H202 formed
in the absence ofplasma (Fig. 3A). Mez-activated PMNs
decrease production of H202 20-fold in the presence of
plasma; TPA-activated cells decrease production by only
10-fold. At20min incubation time, the effect ofplasma is
smaller, but there is 6-fold inhibition in the case of RPA,
5.5 with Mez, and 4 with TPA. At 30 min incubation, that
decrease is 6-, 3-, and 2-fold for RPA, Mez, and TPA,
respectively.
The differences in the degree ofinhibition would favor
the hypothesis that it is the inhibition ofH202 formation
by some plasma components which plays a major role in
the apparent decrease in H202 accumulation. Tumor
promoters would have to overcome this inhibition, and the
ability to do so may depend on the potency of those
promoters. These findings show that even in the presence
ofplasma, the differences in the ability to activate PMNs
among these tumor promoters not only remain but are
even more pronounced, and that again TPA is the most
effective, whereas RPA is the least effective of the
three-the same order of activity as in vivo.
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FIGURE 3. Formation ofH202 by PMNs (1 x 105/mL) activated with 25
nM agents in the absence (A) and the presence (B) of10lo autologous
plasma and incubated at 370C between 10 and 60 min. Left abscissa:
absorbance at 590 nm. Right abscissa: concentration ofH202 as read
from a standard curve. (A)TPA(@-*), Mez(A---A), RPA(0 -U) and
phorbol (x x). Reprinted from Frenkel and Chrzan (34). (B) TPA
(0-0), Mez, (A---A), and RPA (0l---El).
Formation of Oxidized Bases in DNA
Exposed to Activated PMNs
Since the most important characteristic of the first-
stage tumor promoters seems to be an induction of a
heritable DNA damage, we have decided to determine
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whether active oxygen species generated by tumor
promoter-activated PMNs are capable ofcausingmodifi-
cation of DNA bases. To achieve this goal, DNA prela-
beled with [6-3H] thymidine (40) was coincubated with tu-
mor promoter-stimulated PMNs. DNA was then
enzymatically digested to 2'-deoxyribonucleosides, which
were analyzedby HPLC on the reverse-phase column in
the presence ofvarious thymidine derivatives as markers.
These types ofmarkers were used because thymine moi-
ety is known tobe the most susceptible ofthe DNAbases
to the ionizing radiation-induced DNA damage (28,41).
Since that damage is known to be mediated through the
action of * OH, it seemed likely that active oxygen spe-
cies generated by the stimulated PMNs will also cause
the same type ofdamage. Indeed, two thymidine deriva-
tives, 5-hydroxymethyl-2'-deoxyuridine (HMdU) and
thymidine glycol (dTG) (Fig. 4) were identified in DNA
that was exposed to the activated PMNs (34,42,43).
TPA-Induced PMN Activation
In theAbsence ofPlasma. As Table 1 shows, there are
9 HMdU and31 dTG(sample-control) residuesformedper
106 thymidine residues in DNA coincubated with TPA-
stimulated PMNs. These values aregreatly increased in
the presence ofFe2+ ions chelated to EDTA. What is also
interesting is that the time of addition of the Fe/EDTA
complex to the incubation mixture influences the overall
amounts ofthe oxidized thymidines produced. Thus, ad-
dition ofthe complex at the same time as TPA(O time) or
10, 15, and 20 min after TPA, results in 5-, 13-, 30-, and
35-fold increases in HMdU formation and 6-, 7-, 6.5-, and
5-fold increases in dTGs. Thesefindings show that Feions
are necessary for the formation ofthe ultimate damaging
species. They also show thatifmore H202 accumulates be-
fore addition ofFe/EDTA, higher * OH flux canbe gener-
ated, which leads to an increase in theproduction ofoxi-
dized DNA bases, again pointing to the involvement of
H202 in such amodification. The surprisefindingwasthat
although dTG is initially formed at higher levels than
HMdU, increased amounts of generated * OH caused a
relatively small increase in dTG, followed by a decline.
What we found eventually was that * OH generated by
Fe2+-reduced H202 not only causes formation ofdTG but
its decomposition as well, whereas HMdU is not suscep-
tible to such decomposition (43).
In thePresence ofPlasma. Anotherunexpectedresult
was a great enhancement of thymine oxidation in the
presence of autologous plasma. Human blood serum is
known to contain free radical scavengers and antioxidants
(38,39,44), andtherefore a decrease in DNA damage was
anticipated. Instead, the results offour experiments (Ta-
ble 1) show that plasma increases levels ofHMdU by 65
to 1800times. The divergence ofthe results is not that un-
expectedbecause the contentofhuman serum varies even
within the same individual depending on the food intake
and the presence ofvitamins such as A, C, and E, among
other factors.
We also have found thatlevels ofH202 generated vary,
not only among individuals but also among samples of
PMNs from the same individual but obtained on differ-
ent dates(34). However, the d'-e,ee ofenhancementofox-
idized thymines formed in DNA exposed to PMN-
generated active oxygen speciesin thepresence ofplasma
is puzzling. We have established that H202 is involved in
formation ofthat damage since catalase prevents it (un-
published data). Knowing that Fe is needed for the for-
mation of * OH from H202, we looked for the potential
source ofthat iron and it seemed that transferrin, a ubi-
quitous (2-3.2 mg/mL serum) Fe-containingprotein, may
have served as acatalyst. Asitturns out, Fe-loaded trans-
ferrin is capable ofcatalyzingformation ofHMdU(43). Fe
complexed to transferrin is approximately 25 times more
effective than Fe chelated to EDTA. When DNA is ex-
posed to active oxygen species generated by stimulated
PMNs, otherplasmacomponentsmaymodulate the cata-
lytic effects oftransferrin. In particular, other proteins,
by being substrates for a nonspecific oxidation, should
protect DNA. However, human albumin, which is the
most abundant serumprotein(60-80mg/mL serum), does
not decrease HMdU formation.
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FIGURE 4. Structures of some derivatives of thymine moiety formed
through the effects ofradiolytically derived hydroxyl radicals; bases
when R = H and 2'-deoxyribonucleosides when R = 2'-deoxyribose,
(1) thymine; (2) 5-hydroxymethyluracil; (3) thymine glycol; (4)
N'-formyl-N-pyruvylurea; (5) 5-hydroxy-5-methylhydantoin; (6) N-
formylurea; (7) urea. Reprinted from Frenkel et al. (43).
Table 1. Formation of HMdU and dTG in DNA exposed to the
activated PMNs.a
Time of HMdU dTG
Fe/EDTA Formed per Radiation formed per
Treatment addition after 106 dTb equivalency, 106 dTb
of PMNs TPA, min residues Gy residues
DMSO -c 7 0.26 38
TPA - 16 0.60 69
TPA 0 50 1.87 191
TPA 10 123 4.59 228
TPA 15 280 10.45 207
TPA 20 325 12.13 147
TPA + plasma - 650 24.26 790
TPA + plasma - 1,140 42.73 540
TPA + plasma - 8,000 298.6 0
TPA + plasma - 17,900 668 0
aBased on Frenkel et al. (43).
bdT, thymidine.
c-, Fe/EDTA was not added.
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Presence of plasma also changes the levels of dTG in
DNA. At the lowest amount ofHMdU(65/106 thymidines)
therewasmore dTG(79/106)than HMdU, but withthe in-
creased HMdU formation, levels ofdTG decreased, down
to the nondetectable (Table 1). The increase in the levels
ofHMdU attests to the formation of *OH. Therefore, this
difference in response is likely to be due to the suscepti-
bility of dTG to the degrading effects of Fe-mediated
generation of * OH from H202, as wefoundto be the case
in the absence ofplasma. These results show that in ad-
dition to HMdU and dTG, other dTG-derived decompo-
sition products, some ofwhich are included in Figure 4,
may be formed in such DNA. It is likely that in addition
to modified thymines, other oxidized products such as
8-hydroxyguanine are alsoformed in DNAexposedtotu-
mor promoter-stimulated PMNs.
Radiation equivalency values (Table 1), which provide
acomparison between HMdUformation in DNAexposed
to active oxygen species generated by TPA-stimulated
PMNs and HMdU formed in DNAby ionizing radiation,
show that human PMNs have apotential to cause exten-
sive DNA damage. HMdU, which also can be incorpo-
rated into the DNA ofbacterial and mammalian cells, is
cytostatic and cytotoxic and possesses radiomimetic
properties in that it causes diarrhea and leukopenia in
mice (45-48). In addition, HMdU ismutagenic inbacterial
and mammalian cells, and its mutagenic effects are com-
parable in many ways to those caused by ionizing radia-
tion (49). Thus, it is likely that HMdU is among those
modified bases that are responsible for the heritable ef-
fects ofthe first-stage tumor promoters. It is difficult to
predict whether dTG may also be responsible for the
heritable changes because it is known to provide a repli-
cation block (50,51) and, thus, may constitute a lethal
ratherthan amutageniclesion. However, since dTGgives
rise to a number of the decomposition products (Fig. 4)
(52,53), some ofthem may contribute to the memory ef-
fects.
Effects of Mez and RPA on Formation of
HMdU and dTG
We have found that invitroformation ofH202by tumor
promoter-activated PMNs correlates with their in vivo
first-stage promoting potency, with TPA being the most
effective in generating H202, followed by Mez and RPA
(34). As TPA-stimulated PMNs cause formation ofHMdU
and dTG in DNA exposed to those cells, Mez- and RPA-
activated PMNs should also oxidize thymine moiety but
to alesser extent than TPA. The results ofthose experi-
ments show(Table 2) that when the Fe/EDTA complex is
added 15min aftertumorpromoters, 19 HMdU residues
(per 104 thymidines) are formed with TPA, 14 with Mez,
and 5with RPA as activators ofPMNs. Atthe sametime,
16, 7, and 1 dTG residues (per 104 thymidines) are also
formed withTPA, Mez, and RPA,respectively. Thus, for-
mation ofboth HMdU and dTG in DNAexposed to tumor
promoter-activated PMNs correlates with thefirst-stage
potency ofthe activating agents. HMdU is probably the
Tible 2. Number of HMdU and dTG per 104 thymidine residues in DNA
exposed to TPA-, Mez-, and RPA-activated PMNs.a
Tumor promoter HMdU dTG
_ ~~~~~~~1 3
TPA 20 19
Mez 15 10
RPA 6 4
aFe/EDTA (0.1 mM/0.4 mM) was added to human PMNs (1 x 106/mL) that
were pretreated with TPA, Mez, and RPA (25 nM) at 370C for 15 min and in-
cubated togetherfor an additional 45 min. DNA was isolated and analyzed as
described in the legend to Fig. 5.
more reliable marker ofthe two because it is not suscep-
tible tofurther destructive interactionwith OH asisdlT
(43).
Because autologous humanplasma has such aprofound
effect on the formation of oxidized thymines by TPA-
activated cells, the same type ofexperimentswereunder-
taken usingMez and RPA. Figure 5 showsthatwhen the
samePMNpreparations areusedinordertominimizethe
influence ofthe inherentvariability, again, as in the case
ofH202 formation, TPA is the most and RPA is the least
effective in the formation ofHMdU and dTG. A compar-
ison ofthis figure with Table 2 shows that the difference
in the effectiveness of TPA and Mez in the presence of
plasmais evengreaterthaninitsabsence, similarto H202
formation.
TPA
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FIGURE 5. Formation of HMdU and dTG in [3H]DNA (10 jAgImL) ex-
posed to PMNs (1 X 106/mL) that were activated with 25 nM TPA,
Mez, and RPA in the presence of 10% autologous plasma and in-
cubated at 370C for 60nmm. DNA waspurified, enzymatically digested
to 2'-deoxyribonucleosides, and analyzed on the C18 HPLC column
in the presence of"'C-containing HMdU and dTG(43). Fractions coe-
lutingwith the markers were acetylated and again analyzedby HPLC.
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Formation of HMdU in Cellular DNA
Of the active oxygen species generated by stimulated
PMNs, only H202 can easily cross cellular membranes
(23,27,31). Superoxide requires the presence ofion chan-
nels, whereas otherspecies such as OH andhypochlorite
are too reactive to travel far, instead, they interact with
membrane constituents (23,25,31,54). To determine
whether exogenouslyproduced H202 is capable ofdamag-
ing the DNA ofneighboring cells, we looked for the for-
mation ofHMdU in the DNA ofHeLa cells coincubated
withTPA-stimulated PMNsinthepresence of10% autolo-
gous plasma. Figure 6 shows that HMdU is indeed
formed andthat itsformation is dependent onthe amount
of TPA used for the activation of cells. This figure also
shows that acertain amountofHMdUisformedin HeLa
cells incubatedwith TPAinthe absence ofPMNs. HMdU
isfonned inthe DNA ofHeLacells inincreasing amounts
with the increased concentration ofTPA, until TPAistoo
toxic to the cells, as determined by trypanblue exclusion
(Fig. 7). This finding is very important because it shows
that even in the absence ofan exogenous source ofH202
such as PMNs, tumor promoters can induce intracellular
formation ofactive oxygen species. Suchoxidative activa-
tion ofcellsresults inthemodification ofDNAbases, for-
mation ofwhich can be enhanced by the action ofstimu-
lated phagocytic cells.
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FIGURE 6. Formation ofHMdU in DNA ofHeLa cells prelabeled with
[6 3Hlthymidine (40)through the action ofTPA-activated PMNs. Each
sample (+PMNs) and control (-PMNs) was incubated at the same
time at 370C for 2 hr. DNA was isolated, enzymatically digested to
2'-deoxyribonucleosides, and analyzed by HPLC and microderivati-
zation (40,43). Reprinted from Frenkel and Chrzan (19).
6
4
I-
Ul)
R0
M
2
n
25 100 500 1000
12
m0 m
0
m 8 z
-.4
--4
0
x
--4
4
A
nM TPA
FIGURE 7. Formation of HMdU in DNA of HeLa cells (1.8 x 106/mL)
incubated with TPA at 370C for 2 hr in the presence of 10% human
plasma. DNAwas analyzed as described inthelegend to Fig. 6. Right
abscissa: Percent toxicity was determinedby trypanblue exclusion.
Reprinted from Frenkel and Chrzan (19).
One ofthe major functions ofPMNs is to generate ac-
tive oxygen species in orderto combatinfections (23-25);
however, these oxygen species are known to cause exten-
sive damage to theneighboringtissues, particularlywhen
formed in excessively large amounts or in the absence of
the natural stimuli such as bacteria or other particles
Such conditions occurduringwoundingandinflammation.
Both cause vasodilation thatleadstoinfiltration ofPMNs
and diffusionofplasmato the affected areas(23), andboth
are knownfortheirco-carcinogenic effects(55-57). It has
been shown that catalase prevents cellular injury caused
by H202 derived from TPA-activated PMNs (58,59) and
thatmicewithlowlevels ofcatalase have anincreasedin-
cidence ofduodenal cancer (60). We recently have found
that catalase also inhibits formation of HMdU and dTG
in DNAexposedtoTPA-stimulatedPMNs(19). Therefore,
generation ofH202 by stimulated PMNs in the inflamed
orwounded areas, andaconsequentformationofoxidized
bases in the cellular DNA may be responsible for those
co-carcinogenic effects.
Benzo[ajpyrene-lnduced Formation
of H202
Itisquitewellacceptedthatcomplete carcinogens such
asbenzo[a]pyrene (BaP) exerttheirinitiatingactivityby
forming adducts with some bases in DNA after being
metabolized to the oxygenatedintermediates(61-63), but
it is not certain what constitutes their promoting activ-
ity. It has been suggested that, similar to tumor
promoters, they also induce formation of active oxygen
species, particularly since antioxidantsreducethe carcino-
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genic effects of BaP (64-66). It is not established as yet
by what mechanism and which ofthe species may be in-
volved. The suggestion was made that BaP may also ac-
tivate phagocytic cells in a manner similar to that oftu-
mor promoters (65). We find that this is not the case, as
neither BaPnor7,12-dimethylbenz[a]anthracene (DMBA)
cause activation ofPMNs as measured by H202 formation
whenused at concentrations between 1 pM and 1 mM(un-
published data). It is then apparent that although active
oxygen species can oxidize 7,8-BaP diol (proximate car-
cinogenic metabolite of BaP to 7,8-diol-9,10-epoxide (ul-
timate carcinogenic forn)(67), theparenthydrocarbonit-
self cannot stimulate PMNs to produce those active
oxygen species.
Since BaP is actively metabolized by rat liver micro-
somes and forms numerous oxidized intermediates (68),
we decided to look for the formation of H202 as a by-
product of that process. We found that H202 is indeed
formed by microsomes obtained from 3-methylcholan-
threne (3MC)-induced Fischer 344 (F344) rats (69). H202
is generated in linearly increasing amounts with an in-
creased dose ofBaP, up to near 10,xM H202 with 0.5mM
BaP. What is also interesting and potentially important
is the fact that pyrene, a noncarcinogenic parent ofBaP,
does not cause formation ofH202. Microsomes obtained
from 3MC-induced Sprague-Dawley (SD) rats respond in
a similar mannerto BaPtreatment andproduce compara-
ble amounts of H202. Microsomes of uninduced rats of
both strains showthe same levels ofH202formation in re-
sponse to the same concentrations of BaP.
It previously was shown by Lesko and Lorentzen (66)
thatH202 canbegenerated duringinterconversion ofBaP
diol anddione when catalyzedby NADH dehydrogenase.
Our results show that P-450 reductase activity is about
the same in both strains of rats regardless of whether
theywerepreinduced with3MC ornot, whichis in agree-
ment with the findings ofothers (70). Thus, it is not un-
expected that the leveI ofH202 produced are also simi-
lar. Since H202 can cause oxidative DNA damage in the
presence ofiron ions (43), we next examined DNA coin-
cubated with BaP treated microsomes for the presence
of HMdU and dTG (69).
BaP-Induced HMdU Formation by
Microsomes
Itpreviously was estimated that the oxidative damage
to the DNA of BaP-treated cells is about 20-fold higher
thanformation ofadductswith DNAbases(65). Recently,
it was found that thymine glycol is a part of that oxida-
tive damage (71). That formation of oxidized bases may
be a moregeneral result oftreatment with complete car-
cinogens is shownbythepresence ofthymineglycolinthe
DNA ofcells incubated with N-hydroxy-2-naphthylamine
(71) and of 8-hydroxyguanine in cells treated with
4-nitroquinoline-N-oxide (72). In addition, thymine glycol
is found in cells that are subjected to UV radiation (71),
whereas thymine glycol, 5-hydroxymethyluracil, and
8-hydroxyguanine are present in ionizing radiation-
treated cells (40,73-77).
We find that incubation of microsomes obtained from
3MC-inducedrats with BaP causes anincrease in HMdU
formation as comparedto DNAincubated inthe absence
of BaP (Table 3). Amounts of HMdU formed decreased
significantly when catalasewaspresentinthe incubation
mixture containing BaPtolevelswellbelowthoseformed
inthe absence ofthehydrocarbon. Thislastfindingproves
thatH202 isnecessary fortheformationofHMdUin coin-
cubated DNA. As Table 3 shows, even in the absence of
BaP there is a substantial amount of HMdU formed in
DNA. H202 is also formed, although at an order ofmag-
nitude lower than in the presence of BaP. This points to
the normalprocesses ofmicrosomes asbeingresponsible
forthebackground oxidative damage. These findings are
in agreement with those of Totter (78), who postulated
that oxidative damage caused by normal oxygen metab-
olism is responsible for the occurrence of spontaneous
cancers. He further suggested that these types ofcancer
are the result ofthe sameprimary DNA defects as those
formed by ionizingradiation. As we know, oxidized DNA
bases such as HMdU and dTG formed in DNA by intra-
or intercellularly generated active oxygen species
(19,34,42,43,71) are also formed through the action of
ionizing radiation (40,72-76,79).
Our data show that there is at least an order ofmagni-
tude more HMdU formed in DNA by BaP-treated F344
than by SD microsomes. Even in the absence of the
hydrocarbon, F344 microsomes were thatmuch more ef-
fective. These results are in apparent contrast with for-
mation of H202 and the levels of P-450 reductase which
were the same for both strains. It is possible that the
differences in HMdU formation by microsomes ofthese
strains are due to the differentlevels ofcytochrome P-450
and in thepattern ofBaP metabolism. Also, differing in-
teractions may occur within microsomes of these two
strains that compete with DNAforH202. Inaddition, the
availability ofironions and *0 may alsoplay arole since
in order to be mobilized from ferritin, Fe3 + must be
reducedto Fe2+ (80)in whichform it can catalyze reduc-
tion ofH202 to * OH, the actual DNA damagingspecies.
Inadditionto HMdU, dTGis alsoformed; however, it does
not consistently increase bythe treatment ofmicrosomes
with BaP. This could be due to the fact that dTG is not
onlyformed by H202 in the presence ofFe2+, but also can
Table 3. Number of HMdU per 104 thymidine residues formed in DNA
incubated with rat liver microsomes in the absence and presence
of BaP.a
BaP +
Rat strain Control BaP catalase
Sprague-Dawley 0.5 3.1 NDb
Fischer 344 16.1 (± 9.0)c 40.6 (± 5.9) 5.4
'DNA prelabeled with[6-3H] thymidine (40)(100jg/mL) was incubated with
microsomes (115jg/mL) and NADPH regenerating system at 370C for2.5 hr
in the absence (controls) or presence of 1 mM BaP (samples). DNA was puri-
fied and analyzed for the presence ofHMdU as described in thelegend to Fig. 5
(69). bND, not determined.
cMean value i SD.
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be degraded under the same conditions (43), and our as-
say measures only intact dTG.
Conclusions
Two questions were raised in the "Introduction." The
answer to the first question is that formation ofoxidized
bases in DNA and/or their degradation products most
likely are responsible for the first-stage promotional
event(s). The answer to the second question is that pro-
cesses thatlead to theformation ofactive oxygen species
in the amounts exceedingthe antioxidant capacity ofthe
cells are probably responsible forthe formation ofthe ox-
idative DNA damage. We show that tumor promoters in
vitro can activate PMNs to varying degrees dependingon
their potency as the invivo first-stage tumorpromoters
and, as aresult, varying amounts ofH202 are generated
that correlate with those potencies. Consequently, oxi-
dized bases such as HMdU and dTG are formed in coin-
cubated DNA, the levels ofwhich again correlate withthe
first-stage promotion. In addition, we show that a com-
plete carcinogen such as BaP, which requires oxidative
metabolism for its tumorigenic activity, is capable of
producingoxidative DNAbase modification. Inhibition of
that modification by catalase implicates H202 as a medi-
ator ofsuch damage. The inability ofpyrene, anoncarcino-
genic (81) congener of BaP, to induce formation of H202
strengthens the hypothesis that active oxygen species
generated by carcinogens are involved in the carcinogenic
process(es). The ability of BaP to cause formation of
HMdU and dTG, of an aromatic amine to induce forma-
tion ofdTG, and of4-nitroquinoline-N-oxide to cause for-
mation of8-hydroxy-2'-deoxyguanosine, all suggest that
carcinogen induced processes generating active oxygen
species are responsible for the first-stage promoting ac-
tivity of the complete carcinogens.
Theauthorthanks K. Chrzanforhis excellent technical assistance. This
investigation was supported in part by PHS grant CA 37858, awarded
bythe National Cancer Institute, DHHS, and Center grants CA 13343
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